Filing Details

Accession Number:
0000950170-24-105994
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-12 17:00:03
Reporting Period:
2024-09-10
Accepted Time:
2024-09-12 17:00:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1556263 Syros Pharmaceuticals Inc. SYRS Pharmaceutical Preparations (2834) 453772460
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1883804 Conley Chee C/O Syros Pharmaceuticals, Inc.
35 Cambridgepark Drive
Cambridge MA 02140
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-10 50,000 $1.51 72,504 No 4 P Direct
Common Stock Acquisiton 2024-09-11 50,000 $1.71 122,504 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.52, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.75, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.